• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Teva Pharmaceutical Industries

Teva Pharmaceutical Industries

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Research
  1. Mylan Rejects Teva's Unsolicited $40 Billion Bid--4th Update

    Mylan Rejects Teva's Unsolicited $40 Billion Bid--4th Update

  2. Mylan Rejects Teva's Unsolicited $40 Billion Bid--2nd Update

    Mylan Rejects Teva's Unsolicited $40 Billion Bid--2nd Update

  3. ADR Shares End Mixed; Teva Declines

    ADR Shares End Mixed; Teva Declines

  4. Drug Maker Mylan Sues Law Firm Kirkland & Ellis

    Drug Maker Mylan Sues Law Firm Kirkland & Ellis

  5. Teva Proposes to Acquire Mylan for $82.00 Per Share in Cash and Stock

    Teva Proposes to Acquire Mylan for $82.00 Per Share in Cash and Stock

  6. Teva Offers to Buy Mylan for $40 Billion -- 5th Update

    Teva Offers to Buy Mylan for $40 Billion -- 5th Update

  7. Teva Pharmaceutical Considering Bid for Mylan

    Teva Pharmaceutical Considering Bid for Mylan

  8. Fitch: Generic Copaxone Approval Could Prompt Losses At Teva

    Fitch: Generic Copaxone Approval Could Prompt Losses At Teva

  9. Teva offers to buy Mylan for $40 billion

    Teva offers to buy Mylan for $40 billion

  10. Teva's Deal for Mylan Shows Corporate Israel's M&A Hunger

    Teva's Deal for Mylan Shows Corporate Israel's M&A Hunger

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.